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Introduction
One of the most intrinsic immune defense mechanisms of multi­
cellular organisms is to sacrifice infected cells for the benefit of 
the remaining cells. The major cell death modalities, including 
apoptotic  cell  death,  necrotic  cell  death,  and  pyroptotic  cell 
death, are critical defense mechanisms against microbial infec­
tion (Fig. 1; Bergsbaken et al., 2009; Lamkanfi and Dixit, 2010; 
Zitvogel et al., 2010). For instance, in response to bacterial in­
fection, programmed cell death, such as apoptosis, is induced as 
a host innate immune response. This cell death plays two defen­
sive roles in infection. One is to eliminate pathogens at the early 
stage of infection without emitting alarm signals. The other role 
is to induce dendritic cells (DCs) to engulf apoptotic bodies 
containing infected microbes, which allows extracellular anti­
gens to access MHC I molecules and subsequently induce a 
protective immune response (Elliott and Ravichandran, 2010). 
Cell death can also benefit pathogens: one prominent strategy of 
many bacterial pathogens is to induce the demise of infected 
host cells, which allows the bacteria to efficiently exit the host 
cell, spread to neighboring cells, evade immune cells, and/or 
gain  nutrients.  Meanwhile,  many  bacterial  pathogens,  espe­
cially those capable of invading and multiplying within host 
cells, use multiple mechanisms to manipulate host cell death 
and  survival  pathways  in  order  to  maintain  their  replicative 
compartment (Behar et al., 2010; Kim et al., 2010; Lamkanfi 
and Dixit, 2010).
Professional phagocytes play pivotal roles in sensing bac­
teria through pathogen­associated molecular patterns (PAMPs) 
or danger­associated molecular patterns (DAMPs) by various 
pathogen  recognition  receptors  (PRRs),  including  Toll­like   
receptors (TLRs), NOD­like receptors (NLRs), RIG­I–like re­
ceptors, C­type lectin receptors, and absence in melanoma 2 
(AIM2)–like receptors (Chen and Nuñez, 2010; Davis et al., 
2011). These sensors trigger innate immune responses and en­
hance antimicrobial defense responses. Phagocytes activated in 
response to infection efficiently phagocytose target microbes 
and transport them to lysosomes, where they are ultimately   
degraded. The phagocytes also emit various alarms to further 
amplify innate immune responses (Mosser and Edwards, 2008). 
In addition to acting as front­line defense executioners, macro­
phages provide a safe niche for some bacterial pathogens, such 
as Legionella pneumophila, Mycobacterium tuberculosis, Coxi­
ella burnetii, and Brucella spp. These bacteria have evolved 
mechanisms to manipulate host membrane trafficking, remodel 
bacteria­containing  vacuoles,  modulate  cell  death  signaling, 
and prolong the longevity of the replicative compartment so 
they can survive and multiply therein (Kumar and Valdivia, 
2009; Behar et al., 2010). Non­professional phagocytic cells 
Host cell death is an intrinsic immune defense mechanism 
in  response  to  microbial  infection.  However,  bacterial 
pathogens use many strategies to manipulate the host cell 
death and survival pathways to enhance their replication 
and  survival.  This  manipulation  is  quite  intricate,  with 
pathogens often suppressing cell death to allow replica-
tion and then promoting it for dissemination. Frequently, 
these effects are exerted through modulation of the mito-
chondrial pro-death, NF-B–dependent pro-survival, and 
inflammasome-dependent host cell death pathways dur-
ing  infection.  Understanding  the  molecular  details  by 
which bacterial pathogens manipulate cell death path-
ways will provide insight into new therapeutic approaches 
to control infection.
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are widely used as targets for bacterial pathogens to enhance 
pathogenesis: the mitochondria­dependent pro­death pathway, 
NF­B–dependent pro­survival pathway, and inflammasome­
dependent cell death pathway (Bergsbaken et al., 2009; Lamkanfi 
and Dixit, 2010; Rudel et al., 2010). In this review, we highlight 
some selected examples of the strategies that are used by human 
bacterial pathogens to manipulate these host cell pathways dur­
ing infection (Table I).
The mitochondria-dependent cell  
death pathway
Apoptosis is a major cellular defense response during pathogen 
infection, and the mitochondria play a central role in modulat­
ing the host cell death and survival pathways (Rudel et al., 
2010). Apoptosis is triggered by two different pathways: the 
extrinsic pathway and the intrinsic pathway. The extrinsic path­
way is activated upon stimulation of the transmembrane death 
receptors, including FasL, TNF­R1, and Apo2/Apo3. These   
receptors transmit external apoptotic signaling to the death   
machinery, which results in the activation of the executioners 
caspase­3 and ­7. The intrinsic pathway is initiated through the 
such as epithelial cells also act as front­line defense execution­
ers against microbial intrusion by using various PRRs to recog­
nize PAMPs and DAMPs. Epithelial cells that sense microbial 
infection trigger oxidative stress, ER stress, mitochondrial 
stress,  DNA  stress,  inflammatory  responses,  and  autophagy, 
subsequently activate various antimicrobial defense systems   
including cell death and cell exfoliation (Lamkanfi and Dixit, 
2010; Zitvogel et al., 2010). In addition, many epithelial cells, 
such as gut epithelial cells, are exploited as an infectious foot­
hold by various gastrointestinal pathogens such as enteropatho­
genic E. coli (EPEC), enterohemorrhagic E. coli (EHEC), 
Salmonella Typhimurium, Yersinia, Shigella flexneri, and Heli­
cobacter pylori. These pathogenic bacteria have highly evolved 
mechanisms to manipulate the host cell membrane architecture, 
cell–cell junctions, cytoskeletal dynamics, membrane traffick­
ing, cell cycle progression, and cell death signaling to promote 
bacterial colonization of the gut epithelium (Ray et al., 2009; 
Kim et al., 2010).
Although the mechanisms whereby bacterial pathogens 
manipulate the host cell death pathway vary among different 
pathogens and host cell types, the following three pathways 
Figure 1.  Bacteria-induced host cell death. Bacteria induce host cell death through several distinct modalities, including apoptosis, necrosis, and pyropto-
sis. Apoptosis is a type of noninflammatory programmed cell death that is triggered by two different pathways, the intrinsic (mitochondria-mediated) path-
way and extrinsic (receptor-mediated) pathway. Apoptosis is morphologically characterized by membrane blebbing, cell shrinkage, DNA fragmentation, 
mitochondrial permeability, and caspase (except for caspase-1) activation. In apoptosis, bacteria are retained within apoptotic bodies and engulfed by 
phagocytic cells. Necrosis is characterized by membrane rupture, nuclear swelling, and the release of cellular contents and is accompanied by caspase-
independent inflammation. Necrosis is triggered by ROS production or danger signals, such as lysosomal destabilization, calpain release, and depletion 
of ATP, that are induced upon bacterial infection or physical damage. Pyroptosis is a type of programmed cell death that is coordinated by inflammasome-
mediated caspase-1 activation and accompanied by membrane rupture, DNA fragmentation, and the release of pro-inflammatory cytokines, including IL-1 
and IL-18. PAMPs and DAMPs are recognized by NLR proteins, which assemble the inflammasome to activate caspase-1and trigger pyroptosis.933 Bacterial manipulation of host cell death • Ashida et al.
ultimately induce apoptosis (Fig. 1; Arnoult et al., 2009). Block­
ing or delaying cell death is a prominent strategy used by patho­
gens to promote intracellular survival and replication (Arnoult 
et al., 2009; Rudel et al., 2010).
Manipulation  of  the  mitochondrial  cell  death 
pathway  by  intracellular  pathogens. L. pneumophila 
replicates within alveolar macrophages, during which the patho­
gen postpones host cell death by delivering a subset of effec­
tors, including SdhA and SidF, via a type IV secretion system 
(T4SS;  Fig.  2).  The  mechanism  by  which  SdhA  inhibits   
macrophage cell death remains unclear (Laguna et al., 2006). 
release of signaling factors from the mitochondria. Various in­
trinsic stimuli activate Bcl­2 homology 3 (BH3)–only proteins, 
which overcome the inhibitory effects of anti­apoptotic Bcl­2 
proteins. The activated BH3­only proteins promote the oligo­
merization of pro­apoptotic proteins, such as Bax and Bak, in 
the mitochondrial outer membrane, which results in the release 
of cytochrome c into the cytoplasm. Cytochrome c stimulates 
formation of the apoptosome, a multimeric protein complex 
that  serves  as  a  scaffold  for  the  caspase  activation,  which   
proteolytically activates procaspase­9. Caspase­9 then cleaves and 
activates other caspases that cleave numerous substrates to   
Table I.  Selected examples of bacterial pathogens and host cell death
Bacteria Factor Function Mechanism Host target Reference
Chlamydia  
trachomatis
CPAF Inhibition of apoptosis Degradation of  
proapoptotic proteins
BH3-only  
proteins
Pirbhai et al., 2006
Unknown Inhibition of apoptosis Leads to mislocalizaton  
and prevents proapoptotic activity
Bad Verbeke et al., 2006
EPEC NleH Inhibition of apoptosis Inhibits caspase-3 activation BI-1 Hemrajani et al., 2010
  NleD Inhibition of apoptosis Cleaves JNK via metalloprotease  
activity and inhibits JNK signaling
JNK Baruch et al., 2011
Helicobacter  
pylori
CagA Inhibition of apoptosis Up-regulation of anti-proapoptotic  
protein, Mcl-1
MCL-1 Mimuro et al., 2007
  Unknown Inhibition of apoptosis Activates EGFR–Akt–Bcl2  
antiapoptotic pathway
EGFR Yan et al., 2009
Legionella  
pneumophila
SdhA Inhibition of cell death Inhibits mitochondrial disruption  
and caspase activation
Unknown Laguna et al., 2006
  SidF Inhibition of apoptosis Inhibits apoptosis signaling BNIP3,  
Bcl-rambo
Banga et al., 2007
  LegK1 Inhibition of cell death? Promotes host pro-survival signal  
via NF-B activation
IB, p100 Ge et al., 2009
  LnaB Inhibition of cell death? Promotes host pro-survival signal  
via NF-B activation
Unknown Losick et al., 2010
Flagellin Induction of pyroptosis Induces the NAIP5–NLRC4– 
inflammasome–caspase-1 activation
NLRC4,  
NAIP5
Amer et al., 2006;  
Ren et al., 2006;  
Kofoed and Vance, 
2011; Zhao et al., 2011
Mycobacterium  
tuberculosis
Unknown Inhibition of apoptosis Up-regulation of anti-proapoptotic  
proteins, Mcl-1 and A1
MCL-1, A1 Sly et al., 2003;  
Loeuillet et al., 2006; 
Dhiman et al., 2008
Zmp1 Inhibition of  
inflammasome activation
Inhibits caspase-1 activation  
and IL-1 secretion
Unknown Master et al., 2008
Salmonella  
Typhimurium
Flagellin, PrgJ Induction of pyroptosis Induces the NAIP–NLRC4– 
inflammasome–caspase-1 activation
NLRC4, NAIP2, 
NAIP5
Franchi et al., 2006; 
Miao et al., 2006, 
2010a; Kofoed and 
Vance, 2011;  
Zhao et al., 2011
AvrA Inhibition of apoptosis Modifies acetyltransferase  
activity toward MAPKK and  
inhibits JNK activation
MAPKKs Jones et al., 2008
SopB Inhibition of apoptosis Induction of host pro-survival activity PI3K/Akt Knodler et al., 2005; 
Kum et al., 2011
Shigella flexneri Unknown Induction of necrotic  
cell death
Induces mitochondrial  
dysfunction
BNIP3, CypD Carneiro et al., 2009
  Unknown Inhibit mitochondrial  
dysfunction
Activates Nod1–RIP2–NF-B  
pro-survival signaling
Bcl2 Carneiro et al., 2009
  MxiI Induction of pyroptosis Induces the NLRC4–inflammasome– 
caspase-1 activation
NLRC4 Suzuki et al., 2007; 
Miao et al., 2010a
Yersinia YopJ Induction of apoptosis Inhibition of NF-B and MAPK signaling  
via acetyltransferase activity results in  
induction of apoptosis
MAPKKs,  
IKK
Monack et al., 1997, 
Orth et al., 1999; 
Mukherjee et al., 2006
YopK Inhibition of pyroptosis Prevents inflammasome recognition  
by interacting with T3SS translocon
T3SS translocon 
(bacterial target)
Brodsky et al., 2010; 
Dewoody et al., 2011JCB • VOLUME 195 • NUMBER 6 • 2011   934
with 14­3­3 on the Chlamydia inclusion vacuole through   
an interaction between IncG, a bacterial­encoded inclusion 
protein, and 14­3­3 (Scidmore and Hackstadt, 2001). These 
interactions sequester Bad from the mitochondria, thus allowing 
the pathogen to prevent host cell apoptosis (Fig. 2; Verbeke 
et al., 2006).
Anaplasma phagocytophilum, the causative agent of human 
granulocytic anaplasmosis, infects neutrophils and prevents 
their apoptosis by inhibiting the decrease in the anti­apoptotic 
protein Bfl1 and the loss of mitochondrial membrane potential 
(Ge et al., 2005; Rikihisa, 2010). A recent study determined that 
the Anaplasma T4SS effector Ats­1, which contains an N­terminal 
mitochondria­targeting sequence, can target the mitochondria 
(Niu et al., 2010). Niu et al. (2010) showed that Ats­1 can 
prevent Bax from relocalizing from the cytoplasm into the mito­
chondria and inhibit cytochrome c release in neutrophils, sug­
gesting that Anaplasma has evolved strategies to survive within 
neutrophils (Fig. 2).
These studies suggest that the demise of infected cells is 
an important host innate defense mechanism, and that bacteria 
counteract these host cell death responses during the early stage 
of infection to facilitate their intracellular replication.
SidF targets two pro­apoptotic factors, BNIP3 and Bcl­rambo, 
thereby  inhibiting  mitochondria­mediated  apoptotic  signal­
ing (Banga et al., 2007). Indeed, macrophages infected with a 
L. pneumophila sdhA or sidF mutant undergo more apoptosis 
and  have  reduced  bacterial  replication  than  macrophages   
infected with wild­type Legionella, suggesting that blocking 
the macrophage apoptotic response is important for Legion­
ella pathogenesis.
Chlamydia  spp.  use  multiple  mechanisms  to  prevent 
premature host cell death that involve bacterial factors that 
likely  interact  with  mitochondrial  components  involved  in 
apoptotic cell death (Fig. 2; Fan et al., 1998; Fischer et al., 
2004; Dong et al., 2005; Ying et al., 2005). Chlamydia tra­
chomatis inhibits apoptosis by degrading pro­apoptotic BH3­
only proteins, including Bim, Puma, and Bad (Fischer et al., 
2004; Dong et al., 2005; Ying et al., 2005), and this degrada­
tion is partially mediated by Chlamydia­secreted chlamydial 
protease­like activity factor (CPAF; Pirbhai et al., 2006). Fur­
thermore,  Chlamydia  infection  activates  phosphoinositide­3 
kinase (PI3K), which leads to Akt activation and subsequent 
phosphorylation of the pro­apoptotic protein, Bad (Verbeke   
et al., 2006). Phosphorylated Bad can interact and colocalize 
Figure 2.  Bacterial manipulation of mitochondrial cell death pathways. Legionella deliver SidF and SdhA. SidF interacts with two pro-apoptotic proteins, 
BNIP3 and Bcl-rambo, and inhibits apoptotic signaling. SdhA inhibits host cell death and enhances bacterial survival and replication by an as yet unknown 
mechanism. A. phagocytophilum delivers Ats-1 and prevents the loss of mitochondrial membrane potential (MMP) and Bax translocation to the mitochon-
dria to inhibit apoptosis. EPEC delivers NleH, which interacts with Bax inhibitor 1 (BI-1) and blocks epithelial apoptosis. Chlamydia secrete CPAF, which 
degrades the pro-apoptotic BH3-only proteins, thereby blocking the release of cytochrome c from the mitochondria. Chlamydia infection also inhibits the 
function of the pro-apoptotic protein Bad by causing its phosphorylation by Akt and mislocalization to Chlamydia inclusion vacuoles via its interaction 
with 14-3-3 and IncG. H. pylori delivers the T4SS effector CagA to attenuate epithelial cell apoptosis. The CagA and Grb2 or Crk interaction stimulates 
the ERK1/2 pathway and up-regulates the production of the anti-apoptotic factor MCL-1. H. pylori activates EGFR, thereby up-regulating anti-apoptotic 
signaling involving Akt and Bcl2.935 Bacterial manipulation of host cell death • Ashida et al.
factor (TCF/LEF; Amieva and El­Omar, 2008; Wessler and 
Backert, 2008). CagA is also responsible for dampening apop­
tosis of matured gastric epithelial cells (Mimuro et al., 2007). 
When etoposide, an apoptosis inducer, was orally administered 
to Mongolian gerbils to induce intrinsic apoptotic cell death, 
H. pylori infection of the stomach up­regulated the production 
of ERK, a pro­survival factor, and Mcl­1, an anti­apoptotic 
factor, in a CagA­dependent manner, which promoted H. py­
lori colonization of the gerbil stomach (Mimuro et al., 2007). 
Yan et al. (2009) infected wild­type and kinase­defective epi­
dermal growth factor receptor (EGFR) mice with H. pylori and 
demonstrated that H. pylori–induced EGFR phosphorylation 
stimulated  PI3K­dependent  activation  of  the  anti­apoptotic 
factor Akt, increased expression of the anti­apoptotic factor 
Bcl­2, and decreased expression of the pro­apoptotic factor 
Bax,  suggesting  that  H.  pylori  uses  multiple  mechanisms   
to suppress gastric epithelial cell death and promote infec­
tion (Fig. 2).
Mitochondria­dependent cell death pathways in bacteria–
host interactions have been extensively documented and are 
well recognized as major pathogenic strategies for many bacte­
rial pathogens (Böhme and Rudel, 2009; Lamkanfi and Dixit, 
2010). However, the underlying molecular mechanisms of cell 
death that result from interactions between bacterial factors and 
host factors as well as the biological significance of these inter­
actions in vivo are still unknown. Further studies using animal 
models will be important to evaluate the impact of mitochondria­
dependent and ­independent cell death responses on bacterial 
pathogenesis and disease progression.
Manipulation of the NF-B pro-survival 
pathway by bacterial pathogens
NF­B is one of the master regulators of the innate immune   
response and it functions by activating the host inflammatory 
signaling pathway and cell survival pathway. For example,   
NF­B has been shown to protect against TNF­R1–induced cell 
death by up­regulating NF­B–targeted genes, such as A20, 
FHC, Mn­SOD, XIAP, and Gadd45b. These genes suppress 
signaling events downstream of TNF­R1 activation, which are 
ROS production, MAP kinase kinase (MAPKK) activation, and 
induction of the Jun–N­terminal kinase (JNK) cascade (Bubici 
et al., 2006). Many bacterial pathogens use a variety of mecha­
nisms to manipulate the NF­B–regulated survival pathway in 
order to modulate the host cell death response and thus promote 
intracellular replication and pathogenicity.
L. pneumophila delivers T4SS effectors to manipulate the 
NF­B pro­survival pathway and delay macrophage cell death 
(Fig. 3; Losick and Isberg, 2006; Abu­Zant et al., 2007; Bartfeld   
et al., 2009). The L. pneumophila effector LegK1 phosphory­
lates and inactivates IB and p100, inhibitor proteins of   
NF­B, thus enhancing the activation of the NF­B pro­survival 
pathway (Ge et al., 2009). Legionella also deliver the LnaB 
effector to activate NF­B. Although the functions of LnaB are 
still unclear, introduction of LnaB and an NF­B reporter into 
HEK293T cells showed that LnaB enhanced NF­B activity 
compared with the mock control. In addition, macrophages that 
are infected with a L. pneumophila lnaB mutant had reduced 
Modulation of the mitochondrial cell death path-
way by enteric pathogens. Some gastrointestinal bacterial 
pathogens use countermeasures against the rapid epithelial cell 
death response by interfering with the mitochondria­dependent 
cell  death  pathway  (and  enhancing  the  NF­B  pro­survival 
pathway). EPEC, EHEC, and Citrobacter rodentium use a type 
III secretion system (T3SS) to deliver a subset of effectors into 
the intestinal epithelium. One of these effectors, EspF, has mul­
tiple functions that manipulate a variety of host signaling path­
ways that are involved in cytoskeletal rearrangement, disruption 
of cell–cell junctions, epithelial cell death, and immune modu­
lation (Holmes et al., 2010). EspF, which contains an N­terminal 
mitochondrial targeting sequence, targets the mitochondria and 
stimulates cell death by disrupting the mitochondrial mem­
brane  potential  (Nougayrède  and  Donnenberg,  2004;  Nagai   
et al., 2005). These EspF­dependent cellular responses appear 
to benefit pathogenesis because mice infected with a C. roden­
tium espF mutant have reduced lethality, intestinal hyperpla­
sia, and bacterial loads in the intestine (Deng et al., 2004; Nagai 
et al., 2005). Earlier studies showed that EPEC­infected epi­
thelial cells expressed phosphatidylserine on their surface and 
had DNA fragmentation, but showed no signs of cell shrink­
age, membrane blebbing, or nuclear condensation, which are 
characteristic of late­stage apoptotic cell death (Crane et al., 
1999, 2001). Thus, these findings indicate that EPEC can in­
hibit the host cell death response despite initially triggering it 
through EspF. A recent study provided insight into the mecha­
nisms  by  which  EPEC  inhibits  early  apoptosis.  The  EPEC 
NleH effector targets the ER six­transmembrane protein Bax 
inhibitor­1 (BI­1) to prevent elevated cytoplasmic Ca
2+ levels, 
nuclear  condensation,  caspase­3  activation,  and  membrane 
blebbing of infected epithelial cells (Hemrajani et al., 2010). 
Infection  of  BI­1  knockdown  cells  with  the  EPEC­related 
mouse pathogen, C. rodentium, resulted in the loss of NleH­
dependent anti­apoptotic activity, and mice infected with a   
C. rodentium nleH mutant exhibited increased caspase­3 cleav­
age in the intestinal epithelium compared with mice infected 
with wild­type C. rodentium (Hemrajani et al., 2010). Thus, 
NleH may promote colonization by slowing down enterocyte 
loss from the intestine.
H. pylori can manipulate the gastric epithelial mitochon­
dria­dependent and ­independent cell death pathways to pro­
mote persistent colonization of the stomach mucosa (Fischer   
et al., 2009). H. pylori feeds on nutrients in the mucin layer and 
exudates from epithelial cells that are damaged as a result of 
gastric inflammation, reactive oxygen species (ROS), apopto­
sis, and compromised cell–cell junctions (Fischer et al., 2009). 
H. pylori delivers CagA, a major virulence factor, via a T4SS 
into the gastric epithelium. CagA has multiple activities that 
usurp  signaling  pathways  involved  in  gastric  epithelial  cell 
proliferation, cell death, cell–cell junctions, cell scattering, in­
flammatory responses, and gene regulation, all of which con­
tribute to bacterial colonization and gastritis (Fischer et al., 
2009). For instance, CagA interacts with many cellular pro­
teins  that  activate  a  variety  of  transcriptional  factors  such   
as NF­B, nuclear factor of activated T cells (NFAT), serum 
response factor (SRF), and T cell factor/lymphoid enhancer JCB • VOLUME 195 • NUMBER 6 • 2011   936
strategy to counteract host cell apoptosis was also verified by 
infecting either macrophages with reduced Mcl­1 expression 
(by siRNA knockdown) or bfl1 knockout mice. Both of these 
models exhibited decreased mycobacterial pathogenesis (Sly   
et al., 2003; Dhiman et al., 2008). Recent studies reported that 
M. tuberculosis uses a different strategy at the late stage of in­
fection in order to augment macrophage cell death and facilitate 
the egress of intracellular bacteria and further infection of other 
cells via a yet­uncharacterized caspase­independent pathway 
that shares features of necrosis (Behar et al., 2010).
Salmonella infect the intestinal mucosa using two distinc­
tive pathways, the Salmonella pathogenicity island 1 (SPI­1)–
dependent pathway and SPI­2–dependent pathway. Salmonella 
infection of the gut triggers inflammation due to the delivery of 
effectors via the T3SS­1 and T3SS­2 encoded by SPI­1 and 
SPI­2, respectively (Kaiser and Hardt, 2011). In the SPI­1 path­
way, Salmonella directly invades the intestinal epithelium by 
delivering the SopB, SopE, SopE2, and SipA effectors via the 
T3SS­1, in which bacterial invasion results in acute inflamma­
tory  responses.  In  the  SPI­2  pathway,  Salmonella  is  appre­
hended  by  intestinal  DCs,  which  extend  dendrites  between 
epithelial cells to directly engulf luminal bacteria (Valdez et al., 
2009; Kaiser and Hardt, 2011). Once Salmonella cross the epi­
thelium, the bacteria encounter DCs, macrophages, B cells, and 
T cells, and some bacteria gain further access to the host circu­
lation within CD18
+ cells, which ultimately allows the bacteria 
NF­B  activity  (Losick  et  al.,  2010).  Despite  this  evidence 
showing the enhancement of the NF­B–dependent pro­survival 
pathway by these effectors, additional in vivo studies are required 
because L. pneumophila lacking either LegK1 or LnaB did not 
show a significant replication defect in macrophages (Losick   
et al., 2010).
M.  tuberculosis  uses  two  distinctive  strategies  during 
macrophage infection to control cell death; the pathogen post­
pones cell death early during infection, but induces cell death in 
the later stage of infection to promote bacterial egress from   
infected macrophages. Studies with monocyte­derived THP­1 
cells showed that M. tuberculosis infection up­regulates TLR2/
NF­B signaling, which results in the up­regulation of FLIP,   
a  powerful  inhibitor  of  death  receptor  signaling  (Loeuillet   
et al., 2006). A search for anti­apoptosis–related genes in the   
M. tuberculosis genome led to the identification of the nuoG 
gene, which encodes the NuoG subunit of the type I NADH­ 
hydrogenase, NDH­1, and can neutralize the NOX­2–mediated in­
crease in phagosomal ROS and TNF production and thus inhibit 
apoptosis (Fig. 3; Velmurugan et al., 2007; Miller et al., 2010). 
A M. tuberculosis nuoG mutant decreased the ability to inhibit 
macrophage  apoptosis  and  significantly  reduced  virulence  in 
mice (Velmurugan et al., 2007). The apoptotic phenotype of the 
nuoG mutant was significantly reduced in human macrophages 
treated with a TNF­neutralizing antibody as well as in TNF
/ 
murine macrophages (Miller et al., 2010). The bacterial pathogenic 
Figure 3.  Bacterial manipulation of host pro-survival pathway. M. tuberculosis activates host anti-apoptotic signaling by up-regulating the anti-apoptosis 
genes Mcl-1, bfl1, and FLIP. NuoG dampens Nox2-mediated host signaling, resulting in the inhibition of apoptosis. Legionella deliver LegK1 and LnaB, 
which enhance the pro-survival activity of NF-B. Shigella invasion of the epithelium results in mitochondria permeability transition (MPT)dependent ROS 
production and necrosis-like cell death, which is counterbalanced by the NOD1RIP2NF-BBcl2 pro-survival pathway. PGN, peptidoglycan. Salmo-
nella deliver SopB and AvrA via the T3SS, and they inhibit apoptosis by activating the PI3K–Akt pro-survival pathway via inositol phosphate activity and 
by preventing JNK pro-cell death signaling via acetyltransferase activity, respectively. EPEC also targets JNK signaling by delivering NleD, which uses its 
metalloprotease activity to cleave JNK, thereby inhibiting cell death.937 Bacterial manipulation of host cell death • Ashida et al.
mechanism that clears the bacteria and sends alarms that acti­
vate the host immune system. In addition, the gut epithelium 
undergoes rapid turnover that is sustained by a balance between 
cell proliferation and death, and cell death plays a critical role in 
maintaining this tissue homeostasis. Therefore, the most simple 
and efficient means for bacterial pathogens to prolong cell via­
bility, such as manipulation of NF­B pro­survival signaling, 
and thus promote bacterial growth, would be a “gain in time 
strategy” (Kim et al., 2010).
Inflammasome activation through 
recognition of bacterial infection
Bacterial pathogens deliver cytotoxins and T3SS effectors (as 
well as T3SS components and flagellin) to the host cell mem­
brane and cytoplasm to modify the host cell surface architec­
ture,  induce  membrane  damage,  subvert  cell  signaling,  and 
modulate cell physiology in order to promote infection. Thus, 
bacteria can activate the innate immune system when PAMPs 
and DAMPs in an atypical cellular location are recognized by 
cytoplasmic PRRs such as NLRs. Upon recognition of DAMPs 
and PAMPs, NLRs induce the assembly of the inflammasome, 
which is composed of NLR, ASC, and caspase­1, to drive the 
proximity­induced activation of caspase­1, which results in the 
extracellular release of IL­1 and IL­18 and induces pyroptosis. 
Pyroptosis is a type of inflammatory programmed cell death 
that is coordinated by inflammasome­mediated caspase­1 acti­
vation (Fig. 1; Bergsbaken and Cookson, 2007; Schroder and 
Tschopp, 2010; Davis et al., 2011). For example, NLRP3 senses 
damaged cell membranes, infection by Listeria monocytogenes, 
Shigella, S. Typhimurium, Staphylococcus aureus, Neisseria 
gonorrhoeae, and Chlamydia spp, as well as bacterial pore­
forming toxins (Mariathasan et al., 2006; Willingham et al., 
2007; Abdul­Sater et al., 2009; Duncan et al., 2009; Broz et al., 
2010; Khare et al., 2010). NLRC4 detects bacterial infection 
with  L.  monocytogenes  and  S.  Typhimurium  (Mariathasan   
et al., 2006; Warren et al., 2008; Broz et al., 2010). In addition, 
NLRC4 can sense flagellin and the T3SS rod components of   
S. Typhimurium, L. pneumophila, Pseudomonas aeruginosa, and 
Shigella (Mariathasan et al., 2004; Amer et al., 2006; Franchi   
et al., 2006; Miao et al., 2006, 2008, 2010a; Sutterwala et al., 
2007;  Suzuki  et  al.,  2007).  Recent  reports  show  that  NAIP 
(NLR family, apoptosis inhibitory protein) family members act 
as pathogen sensors that determine the specificity of NLRC4 
inflammasome for different bacterial ligands. In fact, NAIP5 
specifically activates NLRC4 inflammasome in response to fla­
gellin, whereas NAIP2 is required for inflammasome activation 
by T3SS rod components (Ren et al., 2006; Kofoed and Vance, 
2011; Zhao et al., 2011). NLRP1b recognizes Bacillus anthra­
cis lethal toxin, a major virulence factor from B. anthracis.   
Indeed, mutations in the Nlrp1b gene were identified as the suscep­
tibility locus for anthrax lethal toxin­induced macrophage cell 
death in mice (Boyden and Dietrich, 2006). AIM2 binds to   
dsDNA via its C­terminal HIN200 domain, and responds to 
Francisella tularensis and L. monocytogenes infection in murine 
macrophages when these bacteria undergo spontaneous autoly­
sis, resulting in caspase­1 activation and pyroptosis (Fernandes­
Alnemri et al., 2010; Jones et al., 2010; Rathinam et al., 2010; 
to access the mesenteric lymph nodes, spleen, and liver (Valdez 
et al., 2009). An early report with human intestinal epithelial 
cells indicated that TNF and nitric oxide production, which is 
induced upon bacterial infection, leads to a delayed apoptosis 
(Kim et al., 1998). Subsequent studies indicated that infection 
of human intestinal epithelial cells with S. Dublin or the porcine 
intestine with S. Typhimurium induced caspase­3–dependent 
and –independent cell death, but only after prolonged exposure 
to the pathogens, implying that the pathogen is capable of sup­
pressing cell death at the initial stage of infection (Paesold et al., 
2002; Schauser et al., 2005). Recent studies showed that the 
Salmonella AvrA and SopB effectors modulate both inflamma­
tory and cell death responses (Fig. 3). AvrA possesses acetyl­
transferase activity for MAPKKs and strongly inhibits the JNK 
signaling pathway, which helps dampen inflammatory and cell 
death responses (Jones et al., 2008; Du and Galán, 2009). Like­
wise, the EPEC NleD effector was shown to target the JNK   
signaling pathway to inhibit apoptosis. NleD uses its zinc metal­
loprotease activity to cleave JNK (and p38), and thus blocks the 
JNK­mediated  pro­apoptotic  pathway  (Fig.  3;  Baruch  et  al., 
2011). SopB protects epithelial cells from apoptosis by main­
taining the activation of Akt, an anti­apoptosis factor (Knodler 
et al., 2005). The ability of SopB to antagonize apoptosis ap­
pears to be dependent on its inositol phosphatase activity, which 
likely directly up­regulates Akt activity. The protective role of 
Akt2, an isoform of Akt, in Salmonella­induced gastroentero­
colitis was recently verified using Akt2 knockout mice; Salmo­
nella­infected Akt2
/ mice showed enhanced morbidity and 
mortality that was associated with increased bacterial loads in 
the intestine and elevated levels of proinflammatory cytokines 
(TNF, IFN­, and MCP­1), which are associated with increased 
apoptosis, compared with wild­type mice (Kum et al., 2011).
Shigella induce both necrosis­like and apoptosis­like cell 
death in a caspase­1­independent manner upon infection of epithe­
lial cells (Clark and Maurelli, 2007; Carneiro et al., 2009; Faherty 
and Maurelli, 2009). However, the bacteria further manipulate the 
host cell survival pathway by dampening cell death signals until 
the late stages of infection when the bacteria have fully replicated 
and spread among epithelial cells. Shigella can dampen the mito­
chondrial dysfunction–mediated necrotic­like cell death response 
by activating the Nod1–RIP2–NF­B–Bcl­2 pro­survival path­
way (Fig. 3; Carneiro et al., 2009). Consistent with this model, 
Nod1
/ MEFs or NF­B inhibitor–treated epithelial cells infected 
with Shigella have a rapid loss of mitochondria permeability tran­
sition and ROS production, leading to necrotic­like cell death 
(Carneiro et al., 2009). Cell death signaling in response to Shigella 
infection becomes predominant in the later stages of infection,   
and this process depends on the BH­3–only protein BNIP3 and   
cyclophilin D (CypD) in mitochondrial permeability and the tran­
sition to cell death. A kinetic study supports the premise that cyto­
protective signaling is dominant during early bacterial replication 
within epithelial cells but is overwhelmed by cell death signaling 
at a later stage, thereby allowing the bacteria to egress and transit 
toward the lumen (Carneiro et al., 2009).
As discussed here, establishing a protective or replicative 
niche during infection is an essential pathogenic mechanism, 
while the demise of infected cells is an important host defense JCB • VOLUME 195 • NUMBER 6 • 2011   938
However, these signaling pathways are abrogated in the early 
stage of infection. One Yop effector, YopJ, interferes with these 
signaling  pathways,  allowing  Yersinia  to  enhance  apoptosis 
(Fig. 4; Monack et al., 1997). YopJ possesses unique acetyl­
transferase activity that acetylates the serine and threonine resi­
dues in host kinases, including the MAPKKs and the IB kinase 
complex (IKK). YopJ targeting of these kinases can inhibit 
their activity (Orth et al., 1999; Mukherjee et al., 2006), allow­
ing Yersinia to block pro­survival signaling in the initial stage 
of infection in naive macrophages, which instead leads to apop­
tosis. Apoptosis in the initial stage of infection by Yersinia  
is likely to benefit pathogens because the pathogens can kill   
macrophages without inflammatory responses. Nevertheless, 
macrophage activation followed by continuous Yersinia infec­
tion can gradually redirect the initial YopJ­dependent apoptosis 
to YopJ­independent, caspase­1–mediated pyroptosis (Bergsbaken 
and  Cookson,  2007).  It  seems  that  redirection  to  pyroptosis   
in  activated  macrophages  is  the  host  defense  strategy  for 
bacterial clearance. To evade macrophage­directed defensive 
actions, Yersinia deliver the T3SS YopK effector to inhibit in­
flammasome activation and prevent pyroptosis (Fig. 4; Brodsky   
et al., 2010). Interestingly, YopK can interact with the T3SS 
translocon and interfere with T3SS recognition by NLRP3 and 
NLRC4, allowing the bacteria to evade IL­1 secretion and py­
roptosis (Brodsky et al., 2010). A more recent study shows that 
YopK regulates effector translocation through the T3SS from 
inside the host cells, thereby preventing pyroptosis (Dewoody 
et  al.,  2011).  When  bone  marrow–derived  macrophages  are   
infected with a Y. pseudotuberculosis yopK mutant, NLRP3   
Sauer et al., 2010; Tsuchiya et al., 2010; Warren et al., 2010). 
These studies indicate that NLR inflammasomes play a key role 
in host innate defense against a variety of microbes and in main­
taining tissue homeostasis.
Modulation  of  inflammasome  activation  by 
bacterial pathogens. Some bacterial pathogens use distinc­
tive strategies to modulate inflammasome­dependent cell death, 
which is an important pathogenic mechanism to avoid host cell 
death and the release of inflammatory intracellular contents   
during  infection  (Fink  and  Cookson,  2007).  For  example,   
S. Typhimurium evades recognition of NLRC4 by repressing 
the expression of PrgJ, a T3SS­1 rod component, and flagellin 
after phagocytosis, whereby instead expressing T3SS­2, which 
is not detected by NLRC4 (Cummings et al., 2006; Miao et al., 
2006, 2010a). Indeed, when macrophages are infected with a   
S. Typhimurium strain that constitutively expresses flagellin, the 
bacteria are efficiently eliminated (Miao et al., 2010b). Salmo­
nella replicate within macrophages, and during this period the 
pathogen gradually switches from SPI­1 to SPI­2 expression. 
This change in SPI expression appears to allow the bacteria to   
efficiently evade NLRC4–inflammasome activation, thereby pro­
moting bacterial replication and facilitating further infection.
Yersinia use strategies that both inhibit and induce cell 
death during infection of macrophages. Some of the Yop effec­
tors delivered via the T3SS play key roles in modulating host 
innate and adaptive immune responses (Dube, 2009). When 
Yersinia infect naive macrophages, the LPS that is released 
from the bacteria is recognized as a PAMP, which rapidly acti­
vates NF­B– and MAPK­dependent pro­survival pathways. 
Figure 4.  Bacterial manipulation of inflammasome activation. PAMPs or DAMPs (such as dsDNA) generated by bacterial invasion and multiplication in 
macrophages trigger NLRP3-, NLRC4-, AIM2-inflammasome assembly and induce pyroptosis. Yersinia induce apoptosis by YopJ-mediated inhibition of 
pro-inflammatory signaling in the initial stage of infection in naive macrophages. Activated macrophages redirect YopJ-mediated apoptosis to YopJ-independent 
pyroptosis. However, Yersinia prevent inflammasome activation by secreting YopK, which interferes with T3SS recognition by NLRP3 and NLRC4. 
M. tuberculosis Zmp1, a Zn metalloprotease, and F. tularensis MviN, a putative lipid II flippase, prevent inflammasome activation and IL-1 secretion/ 
pyroptosis by unknown mechanisms.939 Bacterial manipulation of host cell death • Ashida et al.
fate of bacterial infection, the integrity of the host innate de­
fense barrier, innate and acquired immunity, and disease out­
come. Bacteria­triggered cell death results in various modes of 
cell death that greatly vary with the host cell type, stage of in­
fection, infectious dosage, physiological condition of the cell, 
bacterial factors, and experimental setting. In addition, our 
understanding of the dynamic interplay between pathogens and 
host innate defense responses in vitro and in vivo are occasion­
ally contradictory. Nevertheless, as has been described here and 
in  other  literature  (Lamkanfi  and  Dixit,  2010;  Rudel  et  al., 
2010), future studies on the cell death response during host–
pathogen  interactions  will  provide  further  insight  into  the 
mechanisms by which cells undergo death as an innate defense 
against microbial infection. Furthermore, a better understand­
ing of the molecular details by which bacterial pathogens ma­
nipulate cell death pathways will undoubtedly provide insight 
into new therapeutic approaches that can be used to control bac­
terial infection and inflammatory disease progression.
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